Arkolith/Insider Trading/VOR/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerVor Biopharma Inc. (VOR) · full profile →Form 4 · filed Apr 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.2M
Net Open-Market Flow
-$10.2M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 10, 2026Sell(S)828$15.75$13K3.9M
Apr 9, 2026Sell(S)135K$16.59$2.2M3.9M
Apr 8, 2026Sell(S)353K$16.32$5.8M4.2M
Apr 8, 2026Sell(S)131K$16.91$2.2M4.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000333) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML